THL Partners Acquires Headlands Research from KKR

August 16, 2025

THL Partners entered into a definitive agreement to acquire Headlands Research, a multinational network of clinical trial sites, from funds managed by KKR. The deal is intended to accelerate Headlands’ clinical trial site expansion and enhance its technology and centralized infrastructure for pharmaceutical and biotech sponsors.

Buyers
THL Partners
Targets
Headlands Research
Sellers
Funds managed by KKR
Location
Florida, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.